Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Highlights

  • Highlights
    Selected Articles from This Issue
    Clin Cancer Res December 1 2020 26 (23) 6075-6075;

CCR Translations

  • CCR Translations
    Next-generation Sequencing of Cerebrospinal Fluid: How Can a Liquid be Like a Solid?
    Melina E. Marmarelis and Joshua M. Bauml
    Clin Cancer Res December 1 2020 26 (23) 6077-6079; DOI:10.1158/1078-0432.CCR-20-3330

  • CCR Translations
    Interleukin-12 Message in a Bottle
    Assunta Cirella, Pedro Berraondo, Claudia Augusta Di Trani and Ignacio Melero
    Clin Cancer Res December 1 2020 26 (23) 6080-6082; DOI:10.1158/1078-0432.CCR-20-3250

  • CCR Translations
    DNA Methylation Profiling of Premalignant Lesions as a Path to Ovarian Cancer Early Detection
    Charles A. Ishak and Daniel D. De Carvalho
    Clin Cancer Res December 1 2020 26 (23) 6083-6085; DOI:10.1158/1078-0432.CCR-20-3331

Reviews

  • Reviews
    Impact of Galectins in Resistance to Anticancer Therapies
    Pilar Navarro, Neus Martínez-Bosch, Ada G. Blidner and Gabriel A. Rabinovich
    Clin Cancer Res December 1 2020 26 (23) 6086-6101; DOI:10.1158/1078-0432.CCR-18-3870

  • Reviews
    Progresses Toward Precision Medicine in RET-altered Solid Tumors
    Carmen Belli, Santosh Anand, Justin F. Gainor, Frederique Penault-Llorca, Vivek Subbiah, Alexander Drilon, Fabrice Andrè and Giuseppe Curigliano
    Clin Cancer Res December 1 2020 26 (23) 6102-6111; DOI:10.1158/1078-0432.CCR-20-1587

Clinical Trials: Targeted Therapy

  • Clinical Trials: Targeted Therapy
    Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I–Related Plexiform Neurofibromas
    Lauren H. Boal, John Glod, Melissa Spencer, Miki Kasai, Joanne Derdak, Eva Dombi, Mark Ahlman, Daniel W. Beury, Melinda S. Merchant, Christianne Persenaire, David J. Liewehr, Seth M. Steinberg, Brigitte C. Widemann and Rosandra N. Kaplan
    Clin Cancer Res December 1 2020 26 (23) 6112-6121; DOI:10.1158/1078-0432.CCR-20-1696

  • Clinical Trials: Targeted Therapy
    Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-resistant Prostate Cancer: A Phase I Study of Concurrent Enzalutamide and Crizotinib
    Abhishek Tripathi, Jeffrey G. Supko, Kathryn P. Gray, Zachary J. Melnick, Meredith M. Regan, Mary-Ellen Taplin, Atish D. Choudhury, Mark M. Pomerantz, Joaquim Bellmunt, Channing Yu, Zijie Sun, Sandy Srinivas, Philip W. Kantoff, Christopher J. Sweeney and Lauren C. Harshman
    Clin Cancer Res December 1 2020 26 (23) 6122-6131; DOI:10.1158/1078-0432.CCR-20-2306

  • Clinical Trials: Targeted Therapy | AuthorChoice
    A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia
    Amer M. Zeidan, Maya Ridinger, Tara L. Lin, Pamela S. Becker, Gary J. Schiller, Prapti A. Patel, Alexander I. Spira, Michaela L. Tsai, Errin Samuëlsz, Sandra L. Silberman, Mark Erlander and Eunice S. Wang
    Clin Cancer Res December 1 2020 26 (23) 6132-6140; DOI:10.1158/1078-0432.CCR-20-2586

  • Clinical Trials: Targeted Therapy
    A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone Receptor–positive HER2-negative Breast Cancer
    Aleix Prat, Yi-Hsuan Tsai, Tomás Pascual, Laia Paré, Barbara Adamo, Maria Vidal, Fara Brasó-Maristany, Patricia Galván, Jan Christoph Brase, Vanessa Rodrik-Outmezguine, Stephen Johnston, Eva Ciruelos and Joel S. Parker
    Clin Cancer Res December 1 2020 26 (23) 6141-6148; DOI:10.1158/1078-0432.CCR-20-2793

  • Clinical Trials: Targeted Therapy | AuthorChoice
    A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor–Positive Breast Cancer
    Ian Krop, Vandana Abramson, Marco Colleoni, Tiffany Traina, Frankie Holmes, Laura Garcia-Estevez, Lowell Hart, Ahmad Awada, Claudio Zamagni, Patrick G. Morris, Lee Schwartzberg, Stephen Chan, Ayca Gucalp, Laura Biganzoli, Joyce Steinberg, Lorenzo Sica, Maureen Trudeau, Denka Markova, Jamal Tarazi, Zhou Zhu, Thomas O'Brien, Catherine M. Kelly, Eric Winer and Denise A. Yardley
    Clin Cancer Res December 1 2020 26 (23) 6149-6157; DOI:10.1158/1078-0432.CCR-20-1693

  • Clinical Trials: Targeted Therapy | AuthorChoice
    Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer
    Lipika Goyal, Cynthia Sirard, Michael Schrag, Michael H. Kagey, Jennifer R. Eads, Stacey Stein, Anthony B. El-Khoueiry, Gulam A. Manji, Thomas A. Abrams, Alok A. Khorana, Rebecca Miksad, Devalingam Mahalingam, Andrew X. Zhu and Dan G. Duda
    Clin Cancer Res December 1 2020 26 (23) 6158-6167; DOI:10.1158/1078-0432.CCR-20-1310

  • Clinical Trials: Targeted Therapy
    Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M–positive Non–Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study
    Ligang Xing, Yueyin Pan, Yuankai Shi, Yongqian Shu, Jifeng Feng, Wei Li, Lejie Cao, Lifeng Wang, Wei Gu, Yong Song, Puyuan Xing, Yutao Liu, Wen Gao, Jiuwei Cui, Nana Hu, Rutian Li, Hua Bao, Yang Shao and Jinming Yu
    Clin Cancer Res December 1 2020 26 (23) 6168-6175; DOI:10.1158/1078-0432.CCR-20-2081

Clinical Trials: Immunotherapy

  • Clinical Trials: Immunotherapy
    Molecular and Immunologic Signatures are Related to Clinical Benefit from Treatment with Vocimagene Amiretrorepvec (Toca 511) and 5-Fluorocytosine (Toca FC) in Patients with Glioma
    William P. Accomando, Aliz R. Rao, Daniel J. Hogan, Aaron M. Newman, Aki Nakao, Ash A. Alizadeh, Maximilian Diehn, Oscar R. Diago, Dawn Gammon, Ali Haghighi, Harry E. Gruber, Douglas J. Jolly and Derek Ostertag
    Clin Cancer Res December 1 2020 26 (23) 6176-6186; DOI:10.1158/1078-0432.CCR-20-0536

  • Clinical Trials: Immunotherapy
    Early Intervention with Lenalidomide in Patients with High-risk Chronic Lymphocytic Leukemia
    Shanmugapriya Thangavadivel, Qiuhong Zhao, Narendranath Epperla, Lindsey Rike, Xiaokui Mo, Mohamed Badawi, Darlene M. Bystry, Mitch A. Phelps, Leslie A. Andritsos, Kerry A. Rogers, Jeffrey Jones, Jennifer A. Woyach, John C. Byrd and Farrukh T. Awan
    Clin Cancer Res December 1 2020 26 (23) 6187-6195; DOI:10.1158/1078-0432.CCR-20-1280

  • Clinical Trials: Immunotherapy | AuthorChoice
    Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors
    Ani S. Balmanoukian, Jeffrey R. Infante, Raid Aljumaily, Aung Naing, Ashish V. Chintakuntlawar, Naiyer A. Rizvi, Helen J. Ross, Michael Gordon, Philip R. Mallinder, Nairouz Elgeioushi, Ignacio González-García, Nathan Standifer, Jennifer Cann, Nicholas Durham, Shahram Rahimian, Rakesh Kumar and Crystal S. Denlinger
    Clin Cancer Res December 1 2020 26 (23) 6196-6203; DOI:10.1158/1078-0432.CCR-20-0452

Precision Medicine and Imaging

  • Precision Medicine and Imaging
    Autoantibody Landscape in Patients with Advanced Prostate Cancer
    William S. Chen, Winston A. Haynes, Rebecca Waitz, Kathy Kamath, Agustin Vega-Crespo, Raunak Shrestha, Minlu Zhang, Adam Foye, Ignacio Baselga Carretero, Ivan Perez Garcilazo, Meng Zhang, Shuang G. Zhao, Martin Sjöström, David A. Quigley, Jonathan Chou, Tomasz M. Beer, Matthew Rettig, Martin Gleave, Christopher P. Evans, Primo Lara, Kim N. Chi, Robert E. Reiter, Joshi J. Alumkal, Alan Ashworth, Rahul Aggarwal, Eric J. Small, Patrick S. Daugherty, Antoni Ribas, David Y. Oh, John C. Shon and Felix Y. Feng
    Clin Cancer Res December 1 2020 26 (23) 6204-6214; DOI:10.1158/1078-0432.CCR-20-1966

  • Precision Medicine and Imaging
    Acute Statin Treatment Improves Antibody Accumulation in EGFR- and PSMA-Expressing Tumors
    Patrícia M.R. Pereira, Komal Mandleywala, Ashwin Ragupathi and Jason S. Lewis
    Clin Cancer Res December 1 2020 26 (23) 6215-6229; DOI:10.1158/1078-0432.CCR-20-1960

  • Precision Medicine and Imaging
    Radiotheranostic Agent 64Cu-cyclam-RAFT-c(-RGDfK-)4 for Management of Peritoneal Metastasis in Ovarian Cancer
    Zhao-Hui Jin, Atsushi B. Tsuji, Mélissa Degardin, Aya Sugyo, Satoshi Obara, Hidekatsu Wakizaka, Kotaro Nagatsu, Kuan Hu, Ming-Rong Zhang, Pascal Dumy, Didier Boturyn and Tatsuya Higashi
    Clin Cancer Res December 1 2020 26 (23) 6230-6241; DOI:10.1158/1078-0432.CCR-20-1205

  • Precision Medicine and Imaging
    Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with BRAF-Mutant Metastatic Non–Small Cell Lung Cancer
    Sandra Ortiz-Cuaran, Laura Mezquita, Aurélie Swalduz, Mihalea Aldea, Julien Mazieres, Camille Leonce, Cecile Jovelet, Anne Pradines, Virginie Avrillon, Washington R. Chumbi Flores, Ludovic Lacroix, Yohann Loriot, Virginie Westeel, Maud Ngo-Camus, Claire Tissot, Christine Raynaud, Radj Gervais, Etienne Brain, Isabelle Monnet, Etienne Giroux Leprieur, Caroline Caramella, Celine Mahier-Aït Oukhatar, Natalie Hoog-Labouret, Frank de Kievit, Karen Howarth, Clive Morris, Emma Green, Luc Friboulet, Sylvie Chabaud, Jean-François Guichou, Maurice Perol, Benjamin Besse, Jean-Yves Blay, Pierre Saintigny and David Planchard
    Clin Cancer Res December 1 2020 26 (23) 6242-6253; DOI:10.1158/1078-0432.CCR-20-1037

  • Precision Medicine and Imaging
    Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer
    François Richard, Samira Majjaj, David Venet, Françoise Rothé, Julien Pingitore, Bram Boeckx, Caterina Marchio, Florian Clatot, François Bertucci, Odette Mariani, Christine Galant, Gert van den Eynden, Roberto Salgado, Elia Biganzoli, Diether Lambrechts, Anne Vincent-Salomon, Giancarlo Pruneri, Denis Larsimont, Christos Sotiriou and Christine Desmedt
    Clin Cancer Res December 1 2020 26 (23) 6254-6265; DOI:10.1158/1078-0432.CCR-20-2268

  • Precision Medicine and Imaging
    Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma
    Amy K. Bruzek, Karthik Ravi, Ashwath Muruganand, Jack Wadden, Clarissa May Babila, Evan Cantor, Leo Tunkle, Kyle Wierzbicki, Stefanie Stallard, Robert P. Dickson, Ian Wolfe, Rajen Mody, Jonathan Schwartz, Andrea Franson, Patricia L. Robertson, Karin M. Muraszko, Cormac O. Maher, Hugh J.L. Garton, Tingtin Qin and Carl Koschmann
    Clin Cancer Res December 1 2020 26 (23) 6266-6276; DOI:10.1158/1078-0432.CCR-20-2066

  • Precision Medicine and Imaging | AuthorChoice
    Long-term Outcomes of Oral Vinorelbine in Advanced, Progressive Desmoid Fibromatosis and Influence of CTNNB1 Mutational Status
    Olivier Mir, Charles Honoré, Ali N. Chamseddine, Julien Dômont, Sarah N. Dumont, Andrea Cavalcanti, Matthieu Faron, Françoise Rimareix, Leila Haddag-Miliani, Cécile Le Péchoux, Antonin Levy, Charles Court, Sylvain Briand, Elie Fadel, Olaf Mercier, Arnaud Bayle, Anaïs Brunet, Carine Ngo, Etienne Rouleau, Julien Adam and Axel Le Cesne
    Clin Cancer Res December 1 2020 26 (23) 6277-6283; DOI:10.1158/1078-0432.CCR-20-1847

Translational Cancer Mechanisms and Therapy

  • Translational Cancer Mechanisms and Therapy
    Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment
    Susannah L. Hewitt, Dyane Bailey, John Zielinski, Ameya Apte, Faith Musenge, Russell Karp, Shannon Burke, Fabien Garcon, Ankita Mishra, Sushma Gurumurthy, Amanda Watkins, Kristen Arnold, James Moynihan, Eleanor Clancy-Thompson, Kathy Mulgrew, Grace Adjei, Katharina Deschler, Darren Potz, Gordon Moody, David A. Leinster, Steve Novick, Michal Sulikowski, Chris Bagnall, Philip Martin, Jean-Martin Lapointe, Han Si, Chris Morehouse, Maja Sedic, Robert W. Wilkinson, Ronald Herbst, Joshua P. Frederick and Nadia Luheshi
    Clin Cancer Res December 1 2020 26 (23) 6284-6298; DOI:10.1158/1078-0432.CCR-20-0472

  • Translational Cancer Mechanisms and Therapy | AuthorChoice
    Itacitinib (INCB039110), a JAK1 Inhibitor, Reduces Cytokines Associated with Cytokine Release Syndrome Induced by CAR T-cell Therapy
    Eduardo Huarte, Roddy S. O'Connor, Michael T. Peel, Selene Nunez-Cruz, John Leferovich, Ashish Juvekar, Yan-ou Yang, Lisa Truong, Taisheng Huang, Ahmad Naim, Michael C. Milone and Paul A. Smith
    Clin Cancer Res December 1 2020 26 (23) 6299-6309; DOI:10.1158/1078-0432.CCR-20-1739

  • Translational Cancer Mechanisms and Therapy
    Methylomic Landscapes of Ovarian Cancer Precursor Lesions
    Thomas R. Pisanic II, Yeh Wang, Hanru Sun, Michael Considine, Lihong Li, Tza-Huei Wang, Tian-Li Wang and Ie-Ming Shih
    Clin Cancer Res December 1 2020 26 (23) 6310-6320; DOI:10.1158/1078-0432.CCR-20-0270

  • Translational Cancer Mechanisms and Therapy | AuthorChoice
    CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes
    Valeria Leuci, Chiara Donini, Giovanni Grignani, Ramona Rotolo, Giulia Mesiano, Erika Fiorino, Loretta Gammaitoni, Lorenzo D'Ambrosio, Alessandra Merlini, Elisa Landoni, Enzo Medico, Sonia Capellero, Lidia Giraudo, Giulia Cattaneo, Ilenia Iaia, Ymera Pignochino, Marco Basiricò, Elisa Vigna, Alberto Pisacane, Franca Fagioli, Soldano Ferrone, Massimo Aglietta, Gianpietro Dotti and Dario Sangiolo
    Clin Cancer Res December 1 2020 26 (23) 6321-6334; DOI:10.1158/1078-0432.CCR-20-0357

  • Translational Cancer Mechanisms and Therapy
    STAT3 Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti–PD-L1
    Theresa A. Proia, Maneesh Singh, Richard Woessner, Larissa Carnevalli, Gayathri Bommakanti, Lukasz Magiera, Srimathi Srinivasan, Shaun Grosskurth, Mike Collins, Chris Womack, Matthew Griffin, Minwei Ye, Susan Cantin, Deanna Russell, Mingchao Xie, Adina Hughes, Nanhua Deng, Deanna A. Mele, Stephen Fawell, Simon Barry, Corinne Reimer, J. Carl Barrett and Patricia McCoon
    Clin Cancer Res December 1 2020 26 (23) 6335-6349; DOI:10.1158/1078-0432.CCR-20-1066

  • Translational Cancer Mechanisms and Therapy
    Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma
    Laia Bassaganyas, Roser Pinyol, Roger Esteban-Fabró, Laura Torrens, Sara Torrecilla, Catherine E. Willoughby, Sebastià Franch-Expósito, Maria Vila-Casadesús, Itziar Salaverria, Robert Montal, Vincenzo Mazzaferro, Jordi Camps, Daniela Sia and Josep M. Llovet
    Clin Cancer Res December 1 2020 26 (23) 6350-6361; DOI:10.1158/1078-0432.CCR-20-1497

  • Translational Cancer Mechanisms and Therapy
    The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval
    Kimberly R. Jordan, Matthew J. Sikora, Jill E. Slansky, Angela Minic, Jennifer K. Richer, Marisa R. Moroney, Junxiao Hu, Rebecca J. Wolsky, Zachary L. Watson, Tomomi M. Yamamoto, James C. Costello, Aaron Clauset, Kian Behbakht, T. Rajendra Kumar and Benjamin G. Bitler
    Clin Cancer Res December 1 2020 26 (23) 6362-6373; DOI:10.1158/1078-0432.CCR-20-1762

  • Translational Cancer Mechanisms and Therapy
    Chloroquine Sensitizes GNAQ/11-mutated Melanoma to MEK1/2 Inhibition
    Amanda Truong, Jae Hyuk Yoo, Michael T. Scherzer, John Michael S. Sanchez, Kali J. Dale, Conan G. Kinsey, Jackson R. Richards, Donghan Shin, Phaedra C. Ghazi, Michael D. Onken, Kendall J. Blumer, Shannon J. Odelberg and Martin McMahon
    Clin Cancer Res December 1 2020 26 (23) 6374-6386; DOI:10.1158/1078-0432.CCR-20-1675

  • Translational Cancer Mechanisms and Therapy
    Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models
    Jessica Bordini, Federica Morisi, Angela Rita Elia, Paolo Santambrogio, Alessia Pagani, Vito Cucchiara, Paolo Ghia, Matteo Bellone, Alberto Briganti, Clara Camaschella and Alessandro Campanella
    Clin Cancer Res December 1 2020 26 (23) 6387-6398; DOI:10.1158/1078-0432.CCR-20-3182

Back to top
PreviousNext
Clinical Cancer Research: 26 (23)
December 2020
Volume 26, Issue 23
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

Issue Highlights

  • Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I–Related Plexiform Neurofibromas
  • Acute Statin Treatment Improves Antibody Accumulation in EGFR- and PSMA-Expressing Tumors
  • Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment
  • Itacitinib (INCB039110), a JAK1 Inhibitor, Reduces Cytokines Associated with Cytokine Release Syndrome Induced by CAR T-cell Therapy

Jump to

  • Highlights
  • CCR Translations
  • Reviews
  • Clinical Trials: Targeted Therapy
  • Clinical Trials: Immunotherapy
  • Precision Medicine and Imaging
  • Translational Cancer Mechanisms and Therapy
Advertisement
  • Most Cited
  • Most Read
Loading
  • Immune Checkpoint Blockade Requires Macrophage CXCL9/CXCL10
  • PDAC and GATA6 Expression
  • Characterization of Glioblastoma Patient-Derived Xenografts
  • Guadecitabine and Carboplatin in Ovarian Cancer
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement